nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

17.10.2020 | Correspondence

Study of Prothrombotic Gene Variations Associated with the Risk of Development of Thrombosis in Patients with Down Syndrome

verfasst von: Chandreswara Raju Kataru, Vinodhini Krishnakumar, Inusha Panigrahi, Meganathan Kannan

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

Dear editor, …

Ismail G, Obrişcă B, Jurubţă R, Andronesi A, Sorohan B, Hârza M (2020) Inherited risk factors of thromboembolic events in patients with primary nephrotic syndrome. Medicina (Kaunas, Lithuania) 56:242CrossRef

Haapaniemi E, Helenius J, Jakovljević D, Soinne L, Syrjälä M, Kaste M et al (2009) Ischaemic stroke patients with heterozygous factor V Leiden present with multiple brain infarctions and widespread atherothrombotic disease. Thromb Haemost 101:145–150CrossRef

Kannan M, Yadav BK, Ahmad F, Biswas A, Saxena R (2009) Modulation of clinical phenotype of Glanzmann’s thrombasthenia by thrombogenic mutations. Clin Chim Acta 403:156–158CrossRef

Kumari B, Srivastava S, Chatterjee T, Vardhan R, Tyagi T, Gupta N, Sahu A, Chandra K, Ashraf MZ (2014) Study of associatedgenetic variants in Indian subjects reveals the basis of ethnicity related differences in susceptibility to venous thromboembolism. Thrombosis 2014:182762. https://doi.org/10.1155/2014/182762CrossRefPubMedPubMedCentral

Hotoleanu C, Trifa A, Popp R, Fodor D (2013) The importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism. Balkan Med J 30:197–203CrossRef

Titel: Study of Prothrombotic Gene Variations Associated with the Risk of Development of Thrombosis in Patients with Down Syndrome
verfasst von: Chandreswara Raju Kataru
Vinodhini Krishnakumar
Inusha Panigrahi
Meganathan Kannan
Publikationsdatum: 17.10.2020
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 3/2021
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-020-01369-7

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Study of Prothrombotic Gene Variations Associated with the Risk of Development of Thrombosis in Patients with Down Syndrome

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Real-world Experience of Rituximab in Immune Thrombocytopenia

Prenatal Screening and Diagnosis of ß-Thalassemia in India: Is ARMS-PCR Enough?

Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis

Screening of Dry Blood Spots from Newborns by Two High Performance Liquid Chromatography (HPLC) Systems: A Comparison of Their Ability to Diagnose Both Sickle and Non-sickle Hemoglobinopathies

Chromosome 7q31 Amplification in Fluorescence In-Situ Hybridization: A Hallmark of Hepatosplenic Gamma Delta T Cell Lymphoma

Proportion of CD34+CD38−CD123+ Leukemia Stem Cells at Diagnosis Varies in ELN Risk Groups and an Emerging Novel Marker for Prognosticating the Intermediate Risk patients of Acute Myeloid Leukemia: A Prospective Study

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie